Ror2 as a therapeutic target in cancer

Pharmacology and Therapeutics

Volumn 150, Issue , 2015, Pages 143-148

  Debebe, Zufan ^a   Rathmell, W Kimryn ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Pseudokinase; Receptor tyrosine kinase; Ror2; Wnt signaling

Indexed keywords

RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR 1; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR 2; UNCLASSIFIED DRUG; WNT PROTEIN; ANTINEOPLASTIC AGENT; ROR2 PROTEIN, HUMAN;

BRAIN DEVELOPMENT; BREAST CANCER; CARCINOGENESIS; COLON CANCER; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; GENE MUTATION; HUMAN; KIDNEY CARCINOMA; LIMB DEVELOPMENT; LIVER CELL CARCINOMA; LUNG DEVELOPMENT; MEDULLOBLASTOMA; MELANOMA; MOLECULARLY TARGETED THERAPY; NEUROBLASTOMA CELL LINE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; TUMOR PROMOTION; ANIMAL; METABOLISM; NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; EMBRYONIC DEVELOPMENT; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; SIGNAL TRANSDUCTION;

EID: 84928380373     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2015.01.010     Document Type: Review

References (80)

1. A.R. Afzal, and S. Jeffery One gene, two phenotypes: ROR2 mutations in autosomal recessive Robinow syndrome and autosomal dominant brachydactyly type B Hum Mutat 22 2003 1 11
2. A.R. Afzal, A. Rajab, C.D. Fenske, M. Oldridge, N. Elanko, and E. Ternes-Pereira Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2 Nat Genet 25 2000 419 422
3. S. Akbarzadeh, L.M. Wheldon, S.M. Sweet, S. Talma, F.K. Mardakheh, and J.K. Heath The deleted in brachydactyly B domain of ROR2 is required for receptor activation by recruitment of Src PLoS One 3 2008 e1873
4. R. Al-Shawi, S.V. Ashton, C. Underwood, and J.P. Simons Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development Dev Genes Evol 211 2001 161 171
5. S.C. Artim, J.M. Mendrola, and M.A. Lemmon Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family Biochem J 448 2012 213 220
6. T.W. Bainbridge, V.I. DeAlmeida, A. Izrael-Tomasevic, C. Chalouni, B. Pan, and J. Goldsmith Evolutionary divergence in the catalytic activity of the CAM-1, ROR1 and ROR2 kinase domains PLoS One 9 2014 e102695
7. P. Bhanot, M. Brink, C.H. Samos, J.C. Hsieh, Y. Wang, and J.P. Macke A new member of the frizzled family from Drosophila functions as a Wingless receptor Nature 382 1996 225 230
8. L. Bi, X. Liu, C. Wang, Y. Cao, R. Mao, and P. Li Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma Int J Clin Exp Pathol 7 2014 987 995
9. J. Billiard, D.S. Way, L.M. Seestaller-Wehr, R.A. Moran, A. Mangine, and P.V. Bodine The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells Mol Endocrinol 19 2005 90 101
10. P. Blume-Jensen, and T. Hunter Oncogenic kinase signalling Nature 411 2001 355 365
11. M. Bordonaro, S. Tewari, C.E. Cicco, W. Atamna, and D.L. Lazarova A switch from canonical to noncanonical Wnt signaling mediates drug resistance in colon cancer cells PLoS One 6 2001 e27308
12. J. Boudeau, D. Miranda-Saavedra, G.J. Barton, and D.R. Alessi Emerging roles of pseudokinases Trends Cell Biol 16 2006 443 452
13. J. Cha, A. Bartos, C. Park, X. Sun, Y. Li, and S.W. Cha Appropriate crypt formation in the uterus for embryo homing and implantation requires Wnt5a-ROR signaling Cell Rep 8 2014 382 392
14. A.J. Chien, W.H. Conrad, and R.T. Moon A Wnt survival guide: From flies to human disease J Invest Dermatol 129 2009 1614 1627
15. P.D. Da Forno, J.H. Pringle, P. Hutchinson, J. Osborn, Q. Huang, and L. Potter WNT5A expression increases during melanoma progression and correlates with outcome Clin Res 14 2008 5825 5832
16. B. Edris, I. Espinosa, T. Muhlenberg, A. Mikels, C.H. Lee, and S.E. Steigen ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour J Pathol 227 2012 223 233
17. A.C. Feike, K. Rachor, M. Gentzel, and A. Schambony Wnt5a/Ror2-induced upregulation of xPAPC requires xShcA Biochem Biophys Res Commun 400 2010 500 506
18. S.A. Forbes, G. Bhamra, S. Bamford, E. Dawson, and C. Kok The Catalogue of Somatic Mutations in Cancer (COSMIC) Current Protocols in Human Genetics 2001 John Wiley & Sons, Inc.
19. C.E. Ford, S.S. Qian Ma, A. Quadir, and R.L. Ward The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis Int J Cancer 133 2013 779 787
20. W.C. Forrester The Ror receptor tyrosine kinase family Cell Mol Life Sci 59 2002 83 96
21. M. Geng, Y.C. Cao, Y.J. Chen, H. Jiang, L.Q. Bi, and X.H. Liu Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis World J Gastroenterol 18 2012 1328 1338
22. J.L. Green, S.G. Kuntz, and P.W. Sternberg Ror receptor tyrosine kinases: Orphans no more Trends Cell Biol 18 2008 536 544
23. X. He, J.P. Saint-Jeannet, Y. Wang, J. Nathans, I. Dawid, and H. Varmus A member of the Frizzled protein family mediating axis induction by Wnt-5A Science 275 1997 1652 1654
24. C. Henry, A. Quadir, N.J. Hawkins, E. Jary, E. Llamosas, and D. Kumar Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both beta-catenin dependent and independent Wnt signalling J Cancer Res Clin Oncol 141 2015 243 245
25. M. Hojjat-Farsangi Small-molecule inhibitors of the receptor tyrosine kinases: Promising tools for targeted cancer therapies Int J Mol Sci 15 2014 13768 13801
26. M. Hojjat-Farsangi, A. Moshfegh, A.H. Daneshmanesh, A.S. Khan, E. Mikaelsson, and A. Osterborg The receptor tyrosine kinase ROR1 - An oncofetal antigen for targeted cancer therapy Semin Cancer Biol 29 2014 21 31
27. D. Huang, S. Jiang, Y. Zhang, X. Liu, J. Zhang, and R. He A new mutation in the gene ROR2 causes brachydactyly type B1 Gene 547 2014 106 110
28. S.R. Hubbard, L. Wei, L. Ellis, and W.A. Hendrickson Crystal structure of the tyrosine kinase domain of the human insulin receptor Nature 372 1994 746 754
29. S. Kani, I. Oishi, H. Yamamoto, A. Yoda, H. Suzuki, and A. Nomachi The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon J Biol Chem 279 2004 50102 50109
30. M. Katoh, and M. Katoh WNT signaling pathway and stem cell signaling network Clin Res 13 2007 4042 4045
31. M. Kobayashi, Y. Shibuya, J. Takeuchi, M. Murata, H. Suzuki, and S. Yokoo Ror2 expression in squamous cell carcinoma and epithelial dysplasia of the oral cavity Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 2009 398 406
32. S.S. Lai, B. Xue, Y. Yang, L. Zhao, C.S. Chu, and J.Y. Hao Ror2-Src signaling in metastasis of mouse melanoma cells is inhibited by NRAGE Cancer Genet 205 2012 552 562
33. D.J. Laird, S. Altshuler-Keylin, M.D. Kissner, X. Zhou, and K.V. Anderson Ror2 enhances polarity and directional migration of primordial germ cells PLoS Genet 7 2011 e1002428
34. E. Lara, V. Calvanese, C. Huidobro, A.F. Fernandez, A. Moncada-Pazos, and A.J. Obaya Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer Mol Cancer 9 2010 170
35. S.E. Lee, S.D. Lim, S.Y. Kang, S.B. Suh, and Y.L. Suh Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma Brain Pathol 23 2013 445 453
36. M.A. Lemmon, and J. Schlessinger Cell signaling by receptor tyrosine kinases Cell 141 2010 1117 1134
37. Y. Liu, J.F. Ross, P.V. Bodine, and J. Billiard Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-3(beta) phosphorylation and promotes osteoblast differentiation and bone formation Mol Endocrinol 21 2007 3050 3061
38. Y. Liu, B. Rubin, P.V. Bodine, and J. Billiard Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase J Cell Biochem 105 2008 497 502
39. K. Maeda, Y. Kobayashi, N. Udagawa, S. Uehara, A. Ishihara, and T. Mizoguchi Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis Nat Med 18 2012 405 412
40. G. Manning, D.B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam The protein kinase complement of the human genome Science 298 2002 1912 1934
41. P. Masiakowski, and R.D. Carroll A novel family of cell surface receptors with tyrosine kinase-like domain J Biol Chem 267 1992 26181 26190
42. T. Matsuda, M. Nomi, M. Ikeya, S. Kani, I. Oishi, and T. Terashima Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development Mech Dev 105 2001 153 156
43. H. Mei, S. Lian, S. Zhang, W. Wang, Q. Mao, and H. Wang High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer Biochem Biophys Res Commun 453 2014 703 709
44. J.M. Mendrola, F. Shi, J.H. Park, and M.A. Lemmon Receptor tyrosine kinases with intracellular pseudokinase domains Biochem Soc Trans 41 2013 1029 1036
45. A. Mikels, Y. Minami, and R. Nusse Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling J Biol Chem 284 2009 30167 30176
46. Y. Minami, I. Oishi, M. Endo, and M. Nishita Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: Their implications in developmental morphogenesis and human diseases Dev Dyn 239 2010 1 15
47. K. Morioka, C. Tanikawa, K. Ochi, Y. Daigo, T. Katagiri, and H. Kawano Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma Cancer Sci 100 2009 1227 1233
48. M. Nishita, S. Itsukushima, A. Nomachi, M. Endo, Z. Wang, and D. Inaba Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization Mol Cell Biol 30 2010 3610 3619
49. M. Nishita, S.K. Yoo, A. Nomachi, S. Kani, N. Sougawa, and Y. Ohta Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration J Cell Biol 175 2006 555 562
50. A. Nomachi, M. Nishita, D. Inaba, M. Enomoto, M. Hamasaki, and Y. Minami Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A J Biol Chem 283 2008 27973 27981
51. U. Nordstrom, E. Maier, T.M. Jessell, and T. Edlund An early role for WNT signaling in specifying neural patterns of Cdx and Hox gene expression and motor neuron subtype identity PLoS Biol 4 2006 e252
52. M.P. O'Connell, J.L. Fiori, M. Xu, A.D. Carter, B.P. Frank, and T.C. Camilli The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma Oncogene 29 2010 34 44
53. M.P. O'Connell, and A.T. Weeraratna Hear the Wnt Ror: How melanoma cells adjust to changes in Wnt Pigment Cell Melanoma Res 22 2009 724 739
54. I. Oishi, S. Sugiyama, Z.J. Liu, H. Yamamura, Y. Nishida, and Y. Minami A novel Drosophila receptor tyrosine kinase expressed specifically in the nervous system. Unique structural features and implication in developmental signaling J Biol Chem 272 1997 11916 11923
55. I. Oishi, H. Suzuki, N. Onishi, R. Takada, S. Kani, and B. Ohkawara The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway Genes Cells 8 2003 645 654
56. I.M. Petrova, L.L. Lahaye, T. Martianez, A.W. de Jong, M.J. Malessy, and J. Verhaagen Homodimerization of the Wnt receptor DERAILED recruits the Src family kinase SRC64B Mol Cell Biol 33 2013 4116 4127
57. K.I. Pinson, J. Brennan, S. Monkley, B.J. Avery, and W.C. Skarnes An LDL-receptor-related protein mediates Wnt signalling in mice Nature 407 2000 535 538
58. N.R. Rasmussen, T.M. Wright, S.A. Brooks, K.E. Hacker, Z. Debebe, and A.B. Sendor Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer J Biol Chem 288 2013 26301 26310
59. U.R. Reddy, S. Phatak, C. Allen, L.M. Nycum, E.P. Sulman, and P.S. White Localization of the human Ror1 gene (NTRKR1) to chromosome 1p31-p32 by fluorescence in situ hybridization and somatic cell hybrid analysis Genomics 41 1997 283 285
60. J.M. Reichert, and V.E. Valge-Archer Development trends for monoclonal antibody cancer therapeutics Nat Rev Drug Discov. 6 2007 349 356
61. J. Roman-Gomez, A. Jimenez-Velasco, L. Cordeu, A. Vilas-Zornoza, E. San Jose-Eneriz, and L. Garate WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia Eur J Cancer 43 2007 2736 2746
62. J. Saldanha, J. Singh, and D. Mahadevan Identification of a Frizzled-like cysteine rich domain in the extracellular region of developmental receptor tyrosine kinases Protein Sci 7 1998 1632 1635
63. G.C. Schwabe, B. Trepczik, K. Suring, N. Brieske, A.S. Tucker, and P.T. Sharpe Ror2 knockout mouse as a model for the developmental pathology of autosomal recessive Robinow syndrome Dev Dyn 229 2004 400 410
64. W. Schwarzer, F. Witte, A. Rajab, S. Mundlos, and S. Stricker A gradient of ROR2 protein stability and membrane localization confers brachydactyly type B or Robinow syndrome phenotypes Hum Mol Genet 18 2009 4013 4021
65. L.K. Shawver, D. Slamon, and A. Ullrich Smart drugs: Tyrosine kinase inhibitors in cancer therapy Cancer Cell 1 2002 117 123
66. Z. Songyang, and L.C. Cantley Recognition and specificity in protein tyrosine kinase-mediated signalling Trends Biochem Sci 20 1995 470 475
67. Z. Songyang, S.E. Shoelson, J. McGlade, P. Olivier, T. Pawson, and X.R. Bustelo Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav Mol Cell Biol 14 1994 2777 2785
68. C. B.B. Stark, T. Reguly, L. Boucher, A. Breitkreutz, and M. Tyers Biogrid: a general repository for interaction datasets Nucleic Acids Res 34 2006 D535 D539 (Database issue)
69. A. Ullrich, and J. Schlessinger Signal transduction by receptors with tyrosine kinase activity Cell 61 1990 203 212
70. H. van Bokhoven, J. Celli, H. Kayserili, E. van Beusekom, S. Balci, and W. Brussel Mutation of the gene encoding the ROR2 tyrosine kinase causes autosomal recessive Robinow syndrome Nat Genet 25 2000 423 426
71. A.T. Weeraratna A Wnt-er wonderland - The complexity of Wnt signaling in melanoma Cancer Metastasis Rev 24 2005 237 250
72. R.R. Wouda, M.R. Bansraj, A.W. de Jong, J.N. Noordermeer, and L.G. Fradkin Src family kinases are required for WNT5 signaling through the Derailed/RYK receptor in the Drosophila embryonic central nervous system Development 135 2008 2277 2287
73. T.M. Wright, A.R. Brannon, J.D. Gordan, A.J. Mikels, C. Mitchell, and S. Chen Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma Oncogene 28 2009 2513 2523
74. T.M. Wright, and W.K. Rathmell Identification of Ror2 as a hypoxia-inducible factor target in von Hippel-Lindau-associated renal cell carcinoma J Biol Chem 285 2010 12916 12924
75. M. Yamada, J. Udagawa, A. Matsumoto, R. Hashimoto, T. Hatta, and M. Nishita Ror2 is required for midgut elongation during mouse development Dev Dyn 239 2010 941 953
76. H. Yamamoto, N. Oue, A. Sato, Y. Hasegawa, H. Yamamoto, and A. Matsubara Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase Oncogene 29 2010 2036 2046
77. H. Yamamoto, S.K. Yoo, M. Nishita, A. Kikuchi, and Y. Minami Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2 Genes Cells 12 2007 1215 1223
78. Y. Ying, and Q. Tao Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers Epigenetics 4 2009 307 312
79. A. Yoda, I. Oishi, and Y. Minami Expression and function of the Ror-family receptor tyrosine kinases during development: Lessons from genetic analyses of nematodes, mice, and humans J Recept Signal Transduct Res 23 2003 1 15
80. E. Zeqiraj, and D.M. van Aalten Pseudokinases - Remnants of evolution or key allosteric regulators? Curr Opin Struct Biol 20 2010 772 781